Oxybuprocaine is a benzoate ester in which 4-amino-3-butoxybenzoic acid and 2-(diethylamino)ethanol have combined to form the ester bond; an ester-based local anaesthetic (ester “caine”) used especially in ophthalmology and otolaryngology. Among its listed roles, it functions as a local anaesthetic, a topical anaesthetic and a drug allergen. It is a benzoate ester, a tertiary amino compound, a substituted aniline and an amino-acid ester. Functionally, it is related to 2-diethylaminoethanol. Its therapeutic use is listed as ophthalmic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Benoxinate, Conjucain, Dorsacain and Oxyriprocaine. Its PubChem CID is 4633.
Oxybuprocaine
| CAS No | 99-43-4 |
|---|---|
| Molecular Formula | C17H28N2O3 |
| Molecular Weight | 308.4 g/mol |
| Synonyms | 2-(diethylamino)ethyl 4-amino-3-butoxybenzoate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Oxybuprocaine is a benzoate ester in which 4-amino-3-butoxybenzoic acid and 2-(diethylamino)ethanol have combined to form the ester bond; an ester-based local anaesthetic (ester "caine") used especially in ophthalmology and otolaryngology.
The listed CAS number is 99-43-4.
The listed molecular formula is C17H28N2O3.
The listed molecular weight is 308.4 g/mol.
2-(diethylamino)ethyl 4-amino-3-butoxybenzoate.
The source lists Benoxinate, Conjucain, Dorsacain and Oxyriprocaine.